Le Lézard
Classified in: Business
Subject: MAV

MEDIA ADVISORY - National Housing Strategy


ST. JOHN'S, Nov. 23, 2017 /CNW/ - The Honourable Seamus O'Regan, Member of Parliament for St. John's South ? Mount Pearl, on behalf of the Honourable Jean-Yves Duclos, Minister of Families, Children and Social Development and Minister Responsible for Canada Mortgage and Housing Corporation, will announce Canada's National Housing Strategy in St. John's.

Date:

November 24, 2017



Time:

1:00 p.m.



Location:

Cochrane Street United Church

Stewart Avenue Entrance

St. John's, NL

 

SOURCE Canada Mortgage and Housing Corporation


These press releases may also interest you

at 08:05
Cutera, Inc. ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the first quarter ended March 31, 2024, after the market close on Thursday, May 9, 2024....

at 08:05
The Beauty Health Company , home to flagship brand Hydrafacialtm, today announced it will report first quarter 2024 financial results after market close on Thursday, May 9, 2024. The Company will host an investor conference call at 4:30 p.m. Eastern...

at 08:05
Bragg Gaming Group Inc. ( NASDAQ: BRAG , TSX: BRAG ) (" Bragg " or the " Company"), a global B2B gaming technology and content provider, announced today that it will release its first quarter 2024 financial results prior to the opening of the...

at 08:05
Piper Sandler Companies has released its most recent financial results. The complete earnings release can be found on the firm's website at pipersandler.com/earnings Join the earnings conference call on Friday, April 26, 2024 at 8:00 a.m. CT....

at 08:05
CPI Card Group Inc. ("CPI Card Group"), a payments technology company and leading provider of credit, debit, and prepaid card and digital solutions, including Software-as-a-Service-based instant issuance, today announced it will host a webcast and...

at 08:05
Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (MDNAF: OTCQB), a clinical-stage immunotherapy company focused on the development of engineered cytokines, today announced a CA$20 million investment by RA Capital Management, a multi-stage...



News published on and distributed by: